Allosteric coupling asymmetry mediates paradoxical activation of BRAF by type II inhibitors.
- Published in:
- eLife, 2024, p. 1, doi. 10.7554/eLife.95481
- By:
- Publication type:
- Article
Works by Levinson, Nicholas M.
Results: 8
1
2
Development of allosteric and selective CDK2 inhibitors for contraception with negative cooperativity to cyclin binding.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-38732-x
- By:
- Publication type:
- Article
3
Aurora A binds to the transactivation domain of c-Myc and recognizes the phosphorylated N-terminal degron motif.
- Published in:
- Biochemical Journal, 2025, v. 482, n. 8, p. 369, doi. 10.1042/BCJ20240726
- By:
- Publication type:
- Article
4
The pseudokinase domains of guanylyl cyclase–A and –B allosterically increase the affinity of their catalytic domains for substrate.
- Published in:
- Science Signaling, 2019, v. 12, n. 566, p. N.PAG, doi. 10.1126/scisignal.aau5378
- By:
- Publication type:
- Article
5
Structural and Spectroscopic Analysis of the Kinase Inhibitor Bosutinib and an Isomer of Bosutinib Binding to the Abl Tyrosine Kinase Domain.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0029828
- By:
- Publication type:
- Article
6
A dynamic mechanism for allosteric activation of Aurora kinase A by activation loop phosphorylation.
- Published in:
- eLife, 2018, p. 1, doi. 10.7554/eLife.32766
- By:
- Publication type:
- Article
7
A conserved water-mediated hydrogen bond network defines bosutinib's kinase selectivity.
- Published in:
- Nature Chemical Biology, 2014, v. 10, n. 2, p. 127, doi. 10.1038/nchembio.1404
- By:
- Publication type:
- Article
8
Exploring the conformational landscapes of protein kinases: perspectives from FRET and DEER.
- Published in:
- Biochemical Society Transactions, 2024, v. 52, n. 3, p. 1071, doi. 10.1042/BST20230558
- By:
- Publication type:
- Article